CalciMedica's Auxora treatment reduces inflammation in AKI rat model.

lunes, 10 de noviembre de 2025, 7:03 am ET1 min de lectura
CALC--

• CalciMedica's Auxora reduces IL-17-related inflammation in AKI rat model. • Auxora increases glomerular filtration rate and decreases renal injury. • Auxora being evaluated in Phase 2 KOURAGE trial for severe AKI with respiratory failure.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios